Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Toxic byproduct of hemoglobin could provide clues for cerebral hemorrhage and Creutzfeldt-Jakob Disease

  • Talk about yourself on social media?

  • Brain's gardeners: Immune cells 'prune' connections between neurons

  • Depression, anxiety may reduce chances of IVF pregnancy

  • Imaging shows impact of PTSD in earthquake survivors

  • Genetics and brain regions linked to sex differences in anxiety-related behavior in chimpanzees

  • Brain tune-up may aid self-motivation

  • Asthma symptoms linked to increased stress, anxiety levels in teens

  • 30 small neurons join forces against pain

  • Discovery of a 'neuronal big bang' in brain of newborns

  •